Optimization of Positive End Expiratory Pressure by Use of Pulmonary

Status Recruiting

Clinical Trial Summary

This is an open-label, randomized controlled study comparing two non-invasive ventilation initiation strategies.Patients may be included if they present with acute respiratory failure related to blunt chest trauma.The intervention group will benefit from the use by the physiotherapist of pulmonary ultrasound for the adjustment of Positive End Expiratory Pressure (PEEP) during the 1st session. The conventional group will benefit from the non-invasive ventilation according to the current care.

Clinical Trial Description

This is an open-label, randomized controlled study comparing two non-invasive ventilation initiation strategies. Patients may be included if they are admitted to intensive care unit or continuing care unit and present with acute respiratory failure related to blunt chest trauma. We will not include patients with another indication for non-invasive ventilation, immediately needing invasive ventilation, a contraindication to non invasive ventilation or an estimated length of stay less than or equal to 48 hours. Both groups will be treated with non-ivasive ventilation according to the medical prescription. The intervention group will benefit from the use by the physiotherapist of pulmonary ultrasound for the adjustment of PEEP during the 1st session. The conventional group will benefit from the non-invasive ventilation according to the usual care. The other non-invasive ventilation settings will be chosen with the same method in both groups. The main endpoint will be the PaO2/FiO2 ratio (Arterial oxygen pressure / inspired fraction of oxygen) after 30 min of non-invasive ventilation treatment. This ratio is the best reflection of the patient oxygenation and currently used for respiratory therapies studies. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06072339
Study type	Interventional
Source	University Hospital, Montpellier
Contact	David CHAPEAU, Physiotherapist
Phone	0467332688
Email	d-chapeau@chu-montpellier.fr
Status	Recruiting
Phase	N/A
Start date	November 19, 2023
Completion date	November 7, 2024

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05756387` - Improving Chronic Nocturnal Noninvasive Ventilation: a Multimodality Approach
Not yet recruiting	`NCT06259565` - Non-invasive Ventilation and Dexmedetomidine in Critically Ill Adults	Phase 3
Completed	`NCT02973373` - MRI of the Chest Under High Frequency Ventilation	N/A
Recruiting	`NCT04054622` - Patient-ventilator Asychrony During Non-invasive Ventilation When COPD Patients Doing Exercise
Completed	`NCT03859947` - High-flow Nasal Cannula Flow Rates, Severe Bronchiolitis
Completed	`NCT03149835` - NIV Reduces CBF in COPD Patients Without Cognitive Function	N/A
Recruiting	`NCT04036175` - Comparison of Patient Work of Breathing and Tidal Volumes With High Flow Nasal Cannula Oxygen Therapy and NIV (Non-Invasive Ventilation) After Extubation in the ICU.	N/A
Recruiting	`NCT02712190` - Evaluation of Prolonged Apnea Supported by High Frequency Non-invasive Ventilation.	N/A
Not yet recruiting	`NCT05435183` - Effect of Noninvasive High Frequency Oscillatory Ventilation on Improving Carbon Dioxide Clearance in AECOPD Patients	N/A
Recruiting	`NCT05796297` - Clinical Impact of Patient-ventilator Asynchrony
Not yet recruiting	`NCT05850195` - Assessment Of Different Indices in Prediction of Noninvasive Ventilation Failure in Patients With Acute Respiratory Failure
Not yet recruiting	`NCT05448417` - Exploration of Non-invasive High-frequency Oscillations in Human-machine Asynchrony in Healthy Subjects	N/A
Completed	`NCT05031650` - Open Lung Strategy During Non-Invasive Respiratory Support of Very Preterm Infants in the Delivery Room	N/A
Completed	`NCT03130361` - Wearable Noninvasive Positive Pressure Ventilation Device in COPD	N/A
Completed	`NCT04178694` - The Influence of Non-invasive Ventilation on Metabolism in Healthy Volunteers	N/A
Not yet recruiting	`NCT05706467` - The Difference Between Non-invasive High-frequency Oscillatory Ventilation and Non-invasive Continuous Airway Pressure Ventilation in COVID-19 With Acute Hypoxemia	N/A
Not yet recruiting	`NCT05721833` - Effect of Noninvasive High Frequency Oscillatory Ventilation on Improving CO2 Clearance in COPD Patients	N/A
Recruiting	`NCT01961245` - Effects of Nocturnal Non-invasive Ventilation on Energy Expenditure in Patients With Severe Chronic Obstructive Pulmonary Disease	N/A
Recruiting	`NCT03978221` - Tissue Doppler Ultrasound During Spontaneous Breathing and Non-invasive Ventilation in the Post-extubation Period.	N/A
Completed	`NCT04884828` - Asynchronies in NIV With External Gas

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Optimization of Positive End Expiratory Pressure by Use of Pulmonary Ultrasound for Patients With Blunt Chest Trauma Treated by Non-Invasive Ventilation (Opti-PEP). — Opti-PEP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms